Calendar

Monday Jun 23,2025
Estimate Eps
Actual Eps
Eps Surprise
Estimate Revenue
Actual Revenue
Revenue Surprise
Period
logo
FDS
FactSet
4.3 USD
4.27 USD
-0.70%
580.90M USD
585.50M USD
+0.79%
Q3 2025
Backtest
The backtest results indicate that FDS shows strong positive performance after missing earnings expectations, with win rates reaching 100% at 10 and 30 days and returns increasing up to 6.66% over 30 days. This demonstrates a pronounced market rebound following an initial negative reaction to FDS earnings misses. In contrast, the broader capital markets industry shows negligible impact from earnings misses, with minimal returns and no clear trends, suggesting sector-wide resilience or efficient pricing. Investors may find opportunities in purchasing FDS shares shortly after earnings misses to benefit from the subsequent recovery, while such events in the industry as a whole appear less actionable.
logo
CMC
Commercial Metals
0.85 USD
0.74 USD
-12.94%
2.07B USD
2.02B USD
-2.42%
Q3 2025
logo
JRSH
Jerash Holdings
0.04 USD
-0.01 USD
-125.00%
32.70M USD
29.25M USD
-10.55%
Q4 2025
logo
KBH
KB Home
1.47 USD
1.5 USD
+2.04%
1.51B USD
1.53B USD
+1.32%
Q2 2025
logo
NMR
Nomura Holdings
--
0.76 USD
--
--
12.62B USD
--
FY 2025
logo
CASY
Casey's
13.94 USD
14.72 USD
+5.60%
15.87B USD
15.94B USD
+0.45%
FY 2025
logo
AI
C3.ai
-0.44 USD
-2.24 USD
-409.09%
388.11M USD
389.06M USD
+0.24%
FY 2025
logo
EBF
Ennis
--
0.38 USD
--
99.30M USD
97.20M USD
-2.12%
Q1 2026
logo
EARN
Ellington Credit
--
-0.23 USD
--
--
-14.54M USD
--
Q4 2025
logo
GRCE
Grace Therapeutics
-0.29 USD
0.11 USD
+137.78%
--
--
--
Q4 2025
logo
GRCE
Grace Therapeutics
-1.2 USD
-0.79 USD
+34.62%
--
--
--
FY 2025
logo
DEVS
DevvStream
--
0.12 USD
--
--
10.16K USD
--
Q3 2025
logo
PMTR
Perimeter
--
-0.01 USD
--
--
--
--
Q1 2025